rs111472069

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_178452.6(DNAAF1):​c.919C>G​(p.Gln307Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0234 in 1,613,316 control chromosomes in the GnomAD database, including 599 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 101 hom., cov: 31)
Exomes 𝑓: 0.023 ( 498 hom. )

Consequence

DNAAF1
NM_178452.6 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.272

Publications

10 publications found
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020638406).
BP6
Variant 16-84165838-C-G is Benign according to our data. Variant chr16-84165838-C-G is described in ClinVar as Benign. ClinVar VariationId is 163083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0301 (4557/151586) while in subpopulation AFR AF = 0.0466 (1924/41284). AF 95% confidence interval is 0.0449. There are 101 homozygotes in GnomAd4. There are 2253 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 101 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF1NM_178452.6 linkc.919C>G p.Gln307Glu missense_variant Exon 7 of 12 ENST00000378553.10 NP_848547.4 Q8NEP3-1A0A140VJN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF1ENST00000378553.10 linkc.919C>G p.Gln307Glu missense_variant Exon 7 of 12 1 NM_178452.6 ENSP00000367815.5 Q8NEP3-1

Frequencies

GnomAD3 genomes
AF:
0.0300
AC:
4546
AN:
151466
Hom.:
100
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0464
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0100
Gnomad ASJ
AF:
0.0161
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000831
Gnomad FIN
AF:
0.0677
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0245
Gnomad OTH
AF:
0.0246
GnomAD2 exomes
AF:
0.0205
AC:
5153
AN:
251410
AF XY:
0.0196
show subpopulations
Gnomad AFR exome
AF:
0.0452
Gnomad AMR exome
AF:
0.00781
Gnomad ASJ exome
AF:
0.0153
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0610
Gnomad NFE exome
AF:
0.0219
Gnomad OTH exome
AF:
0.0212
GnomAD4 exome
AF:
0.0227
AC:
33224
AN:
1461730
Hom.:
498
Cov.:
33
AF XY:
0.0222
AC XY:
16136
AN XY:
727154
show subpopulations
African (AFR)
AF:
0.0467
AC:
1562
AN:
33468
American (AMR)
AF:
0.00859
AC:
384
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0153
AC:
401
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00189
AC:
163
AN:
86254
European-Finnish (FIN)
AF:
0.0615
AC:
3284
AN:
53402
Middle Eastern (MID)
AF:
0.00543
AC:
31
AN:
5714
European-Non Finnish (NFE)
AF:
0.0235
AC:
26165
AN:
1111954
Other (OTH)
AF:
0.0204
AC:
1234
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
1762
3524
5286
7048
8810
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
986
1972
2958
3944
4930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0301
AC:
4557
AN:
151586
Hom.:
101
Cov.:
31
AF XY:
0.0304
AC XY:
2253
AN XY:
74058
show subpopulations
African (AFR)
AF:
0.0466
AC:
1924
AN:
41284
American (AMR)
AF:
0.00989
AC:
150
AN:
15160
Ashkenazi Jewish (ASJ)
AF:
0.0161
AC:
56
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5148
South Asian (SAS)
AF:
0.000832
AC:
4
AN:
4810
European-Finnish (FIN)
AF:
0.0677
AC:
708
AN:
10460
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0244
AC:
1661
AN:
67954
Other (OTH)
AF:
0.0243
AC:
51
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
200
399
599
798
998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0223
Hom.:
36
Bravo
AF:
0.0261
TwinsUK
AF:
0.0213
AC:
79
ALSPAC
AF:
0.0249
AC:
96
ESP6500AA
AF:
0.0391
AC:
172
ESP6500EA
AF:
0.0236
AC:
203
ExAC
AF:
0.0202
AC:
2451
Asia WGS
AF:
0.00549
AC:
20
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 11, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gln307Glu in exon 7 of DNAAF1: This variant is not expected to have clinical sig nificance because it has been identified in 3.9% (172/4400) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs111472069). -

not provided Benign:3
Jul 21, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23599692) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DNAAF1: BP4, BS1, BS2 -

Primary ciliary dyskinesia Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 09, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Primary ciliary dyskinesia 13 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
4.0
DANN
Benign
0.22
DEOGEN2
Benign
0.0015
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.015
N
LIST_S2
Benign
0.64
T
MetaRNN
Benign
0.0021
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.89
L
PhyloP100
0.27
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.010
N
REVEL
Benign
0.092
Sift
Benign
0.57
T
Sift4G
Benign
0.88
T
Polyphen
0.0070
B
Vest4
0.029
MPC
0.021
ClinPred
0.0055
T
GERP RS
-2.5
Varity_R
0.055
gMVP
0.22
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111472069; hg19: chr16-84199444; COSMIC: COSV57576718; API